Eliminating Viral Hepatitis By 2030 Possible With Improved Access To Treatments, Increased Funding

The Lancet: Towards elimination of viral hepatitis by 2030
Editorial Board

“…[W]ith some vital progress now made, 2016 could be a turning point for the global prevention and control of viral hepatitis infection. … Although the knowledge and approaches required to eliminate hepatitis such as vaccines and antiviral treatment are already in existence, accessibility and affordability of effective treatment and care services for viral hepatitis are a major concern in most countries. … On July 28, when World Hepatitis Day will be observed, policymakers, health workers, and the public are called upon to ‘know hepatitis-act now.’ To realize the vision of eliminating viral hepatitis by 2030, much more vigorous action to reform health policy — particularly drug price policy — as well as the funding for hepatitis, at both global and national levels, must be taken” (7/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.